Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Nerve growth factor stimulates cellular proliferation of human epithelial ovarian cancer.

Urzua U, Tapia V, Geraldo MP, Selman A, Vega M, Romero C.

Horm Metab Res. 2012 Sep;44(9):656-61. doi: 10.1055/s-0032-1304617.

PMID:
22411587
2.

Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.

Campos X, Muñoz Y, Selman A, Yazigi R, Moyano L, Weinstein-Oppenheimer C, Lara HE, Romero C.

Gynecol Oncol. 2007 Jan;104(1):168-75.

PMID:
16935322
3.

Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer.

Tapia V, Gabler F, Muñoz M, Yazigi R, Paredes A, Selman A, Vega M, Romero C.

Gynecol Oncol. 2011 Apr;121(1):13-23. doi: 10.1016/j.ygyno.2010.12.341.

PMID:
21236475
4.

Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.

Mercier PL, Bachvarova M, Plante M, Gregoire J, Renaud MC, Ghani K, Têtu B, Bairati I, Bachvarov D.

Mol Oncol. 2011 Oct;5(5):438-53. doi: 10.1016/j.molonc.2011.07.003.

5.

Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.

Gaudin F, Nasreddine S, Donnadieu AC, Emilie D, Combadière C, Prévot S, Machelon V, Balabanian K.

PLoS One. 2011;6(7):e21546. doi: 10.1371/journal.pone.0021546.

6.

HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma.

Bu R, Uddin S, Bavi P, Hussain AR, Al-Dayel F, Ghourab S, Ahmed M, Al-Kuraya KS.

Lab Invest. 2011 Jan;91(1):124-37. doi: 10.1038/labinvest.2010.136.

7.

Nerve growth factor induces the expression of chaperone protein calreticulin in human epithelial ovarian cells.

Vera C, Tapia V, Kohan K, Gabler F, Ferreira A, Selman A, Vega M, Romero C.

Horm Metab Res. 2012 Jul;44(8):639-43. doi: 10.1055/s-0032-1311633.

PMID:
22773372
8.

An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response.

Pinciroli P, Alberti C, Sensi M, Canevari S, Tomassetti A.

BMC Genomics. 2013 Jul 26;14:508. doi: 10.1186/1471-2164-14-508.

9.

Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism.

Ma Z, Zhang T, Wang R, Cheng Z, Xu H, Li W, Wang Y, Wang X.

Int J Gynecol Cancer. 2011 May;21(4):616-24. doi: 10.1097/IGC.0b013e3182150e98.

PMID:
21543928
10.

High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion.

Kim HJ, Jeon HK, Cho YJ, Park YA, Choi JJ, Do IG, Song SY, Lee YY, Choi CH, Kim TJ, Bae DS, Lee JW, Kim BG.

Eur J Cancer. 2012 Aug;48(12):1914-21. doi: 10.1016/j.ejca.2012.02.005.

PMID:
22386573
11.

Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells.

Wang ZQ, Keita M, Bachvarova M, Gobeil S, Morin C, Plante M, Gregoire J, Renaud MC, Sebastianelli A, Trinh XB, Bachvarov D.

PLoS One. 2013 Oct 4;8(10):e74384. doi: 10.1371/journal.pone.0074384.

12.

Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.

Ota T, Klausen C, Salamanca MC, Woo HL, Leung PC, Auersperg N.

Differentiation. 2009 Feb;77(2):162-71. doi: 10.1016/j.diff.2008.09.018.

PMID:
19281776
13.

Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.

Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, Gupta A, Suri A.

Clin Cancer Res. 2007 Mar 1;13(5):1421-8.

14.

Cyclin I mRNA expression correlates with kinase insert domain receptor expression in human epithelial ovarian cancer.

Cybulski M, Jeleniewicz W, Nowakowski A, Stenzel-Bembenek A, Tarkowski R, Kotarski J, Stepulak A.

Anticancer Res. 2015 Feb;35(2):1115-9.

PMID:
25667501
15.

Activin is a potent growth suppressor of epithelial ovarian cancer cells.

Ramachandran A, Marshall ES, Love DR, Baguley BC, Shelling AN.

Cancer Lett. 2009 Nov 28;285(2):157-65. doi: 10.1016/j.canlet.2009.05.010.

PMID:
19493612
16.

Role of nerve growth factor and its TRKA receptor in normal ovarian and epithelial ovarian cancer angiogenesis.

Vera C, Tapia V, Vega M, Romero C.

J Ovarian Res. 2014 Aug 10;7:82. doi: 10.1186/s13048-014-0082-6. Review.

17.

Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer.

Song T, Choi CH, Cho YJ, Sung CO, Song SY, Kim TJ, Bae DS, Lee JW, Kim BG.

Gynecol Oncol. 2012 May;125(2):427-32. doi: 10.1016/j.ygyno.2012.01.030.

PMID:
22285843
18.
19.

Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression.

Vermeij R, de Bock GH, Leffers N, Ten Hoor KA, Schulze U, Hollema H, van der Burg SH, van der Zee AG, Daemen T, Nijman HW.

J Immunother. 2011 Jul-Aug;34(6):516-23. doi: 10.1097/CJI.0b013e31821e012f.

PMID:
21654520
20.

SYF2 is upregulated in human epithelial ovarian cancer and promotes cell proliferation.

Yan S, Deng Y, Qiang Y, Xi Q, Liu R, Yang S, Liu J, Tang C, Zhong J, Wang Y.

Tumour Biol. 2015 Jun;36(6):4633-42. doi: 10.1007/s13277-015-3111-1.

PMID:
25623116
Items per page

Supplemental Content

Support Center